Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The research identified key molecules that help hair matrix and dermal papilla cells communicate and influence hair growth in cashmere goats.

Estrogen therapy can reduce skin aging but has cancer risks.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Effective PCOS treatments require targeting specific signaling pathways.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

No cure for female pattern hair loss, but various effective treatments exist.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.